デフォルト表紙
市場調査レポート
商品コード
1427976

精密診断の世界市場レポート 2024

Precision Diagnostics Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
精密診断の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

精密診断の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には13.9%の年間複合成長率(CAGR)で1,638億8,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、リキッドバイオプシー用途の拡大、人工知能(AI)の統合、コンパニオン診断の需要の増大、ポイントオブケア検査の拡大、および人口健康管理の取り組みに起因すると考えられます。予測期間中に予想される主要な動向には、シーケンスにおける技術革新、マルチオミクス技術の進歩、デジタルパソロジーの台頭、現実世界の証拠の統合、研究開発における共同努力が含まれます。

精密診断市場は、慢性疾患の有病率の増加によって成長する準備ができています。慢性疾患は3か月以上続き、時間の経過とともに悪化する可能性があるため、正確な診断ソリューションに対する需要が高まっています。 精密診断は、慢性疾患患者のヘルスケアモデルを管理し、正確な病気の診断を提供する上で重要な役割を果たします。たとえば、2023年 1月の国立医学図書館のデータによると、少なくとも1つの慢性疾患を持つ米国の50歳以上の人の数は2050年までに1億4,266万人に達すると予測されており、増加する慢性疾患に対処する上での精密診断の役割が強調されています。

精密診断市場の成長に貢献するもう1つの要因は、ヘルスケアへの支出の増加です。ヘルスケア支出の増加により、高度な診断ソリューションに多額のリソースが割り当てられ、精密診断の開発と広範な採用が促進されます。これは、パーソナライズされた効果的なヘルスケアソリューションを提供するという業界の取り組みと一致しています。メディケア・メディケイド・サービスセンターが2022年3月に発表した2021~2030年の国民医療支出(NHE)報告書によると、国民医療支出は2021年から2030年にかけて毎年5.1%増加し、6兆8,000億米ドル近くに達すると予想されています。メディケアとメディケイド支出の年々増加に伴うヘルスケア支出の予測成長は、精密診断市場の主要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の精密診断市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 遺伝子検査
  • 難解検査
  • その他のタイプ
  • 世界の精密診断市場、技術別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 次世代シーケンシング(NGS)
  • ポリメラーゼ連鎖反応(PCR)
  • In Situハイブリダイゼーション(ISH)
  • 質量分析法
  • 免疫組織化学(IHC)
  • その他の技術
  • 世界の精密診断市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 腫瘍学
  • 感染症
  • 心臓血管
  • 神経内科
  • 遺伝的疾患
  • その他の用途
  • 世界の精密診断市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院と診療所
  • 診断研究所
  • 研究機関
  • 製薬およびバイオテクノロジー企業
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の精密診断市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の精密診断市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 精密診断市場の競合情勢
  • 精密診断市場の企業プロファイル
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd.
    • Bayer AG
    • Novartis AG
    • Abbott Laboratories

第31章 その他の大手および革新的な企業

  • Danaher Corporation
  • Amgen Inc.
  • Koninklijke Philips NV
  • Becton Dickinson and Company(BD)
  • Thermo Fisher Scientific Inc.
  • Quest Diagnostics Inc.
  • Seimens Healthineers AG
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Beckman Coulter Inc.
  • Charles River Laboratories International Inc.
  • Sysmex America Inc.
  • Waters Corporation
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13820

Precision diagnostics is a subset of precision medicine, focusing on utilizing individual data, including genetic, environmental, and lifestyle information, to enhance the prevention, diagnosis, and treatment of illnesses in healthcare. It involves providing detailed genetic information about a patient's clinical history to aid in the treatment process.

The primary types of precision diagnostics include genetic tests, esoteric tests, and others. Genetic tests involve laboratory examinations aimed at identifying differences in an individual's DNA, such as alterations in chromosomes, genes, or gene expression within their cells or tissues. Various technologies are employed, including next-generation sequencing (NGS), polymerase chain reaction (PCR), in situ hybridization (ISH), mass spectrometry, immunohistochemistry (IHC), and others. These technologies find applications in various fields such as oncology, infectious diseases, cardiovascular health, neurology, genetic disorders, and others. Precision diagnostics are utilized by hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical and biotechnology companies, among others.

The precision diagnostics market research report is one of a series of new reports from The Business Research Company that provides precision diagnostics market statistics, including precision diagnostics industry global market size, regional shares, competitors with a precision diagnostics market share, detailed precision diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the precision diagnostics industry. This precision diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The precision diagnostics market size has grown rapidly in recent years. It will grow from $85.73 billion in 2023 to $97.54 billion in 2024 at a compound annual growth rate (CAGR) of 13.8%. The expansion observed in the historical period can be attributed to advances in genomic research, the rise of personalized medicine, an increasing prevalence of chronic diseases, patient empowerment and informed decision-making, the transition of healthcare systems towards value-based care, and government initiatives and funding.

The precision diagnostics market size is expected to see rapid growth in the next few years. It will grow to $163.88 billion in 2028 at a compound annual growth rate (CAGR) of 13.9%. The anticipated growth in the forecast period can be attributed to the expansion of liquid biopsy applications, the integration of artificial intelligence (AI), the growing demand for companion diagnostics, the expansion of point-of-care testing, and population health management initiatives. Key trends expected in the forecast period encompass technological innovations in sequencing, advancements in multi-omics technologies, the rise of digital pathology, the integration of real-world evidence, and collaborative efforts in research and development.

The precision diagnostics market is poised for growth, driven by the increasing prevalence of chronic diseases. Chronic diseases, lasting three months or more and potentially worsening over time, prompt a growing demand for precise diagnostic solutions. Precision diagnostics play a crucial role in managing healthcare models for patients with chronic conditions, offering accurate disease diagnosis. For instance, data from the National Library of Medicine in January 2023 indicates that the number of individuals aged 50 and older in the US with at least one chronic condition is projected to reach 142.66 million by 2050, emphasizing the role of precision diagnostics in addressing the rising prevalence of chronic diseases.

An additional factor contributing to the growth of the precision diagnostics market is the increased spending on healthcare. Greater healthcare spending allocates substantial resources to advanced diagnostic solutions, fostering the development and widespread adoption of precision diagnostics. This aligns with the industry's commitment to delivering personalized and effective healthcare solutions. According to the 2021-2030 National Health Expenditure (NHE) report from the Centers for Medicare & Medicaid Services in March 2022, national health spending is expected to grow by 5.1% annually between 2021 and 2030, reaching nearly $6.8 trillion. The projected growth in healthcare spending, with annual increases in Medicare and Medicaid spending, is a key driver of the precision diagnostics market.

A notable trend in the precision diagnostics market is the introduction of innovative therapies, with major companies adopting new technologies to maintain their market positions. For example, in July 2021, Xyall BV, a Netherlands-based automated tissue dissection solution company, introduced the Automated High Throughput (HT) system, the world's first high-volume molecular diagnostic solution. This technology enables commercialization of the company's automated tissue dissection technology, enhancing precision diagnostics for high-volume molecular diagnostic laboratories.

Strategic partnerships are a prevalent approach among major companies operating in the precision diagnostics market to deliver personalized and precision-focused healthcare. These partnerships involve leveraging each other's strengths and resources for mutual benefits. In October 2021, HALO Diagnostics, a US-based precision diagnostics company, formed a partnership with Subtle Medical, a US-based healthcare technology company. This collaboration enables HALO to tailor scans to patient requirements, improving workflow efficiency, optimizing the patient experience, and ensuring safety. The integration of Subtle Medical's technology into HALO Diagnostics reflects their commitment to providing precision-focused, personalized healthcare.

In February 2022, SQI Diagnostics Inc., a Canada-based precision medicine company, acquired Precision Biomonitoring Inc. for $6,825,000. This acquisition aims to expand SQI's human diagnostic business portfolio by incorporating Precision Biomonitoring's TripleLock molecular diagnostic testing technology. Precision Biomonitoring Inc., a Canada-based biotechnology and research company, specializes in providing precision diagnostic services, including DNA-based surveillance and detection.

Major companies operating in the precision diagnostics market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Abbott Laboratories, Danaher Corporation, Amgen Inc., Koninklijke Philips N.V., Becton Dickinson and Company (BD), Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Siemens Healthineers AG, Agilent Technologies Inc., PerkinElmer Inc., Beckman Coulter Inc., Charles River Laboratories International Inc., Sysmex America Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Bio-Techne Corporation, Illumina Inc., Lantheus Medical Imaging Inc., Luminex Corporation, BioFire Diagnostics LLC, Genomic Health Inc., Swiss Precision Diagnostics GmbH, Bluebird Bio Inc.

North America was the largest region in the precision diagnostics market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the precision diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The precision diagnostics market consists of revenues earned by entities by providing precision imaging, molecular imaging, on-device X-ray AI algorithms, and automated MR workflow. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision diagnostics market also includes sales of medical diagnostic kits, rapid test kits, instruments and analyzers, and diagnostic equipment which are used in precision diagnostics services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Precision Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on precision diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for precision diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The precision diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Genetic Tests; Esoteric tests; Other Types
  • 2) By Technology: Next Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); In Situ Hybridization (ISH); Mass Spectrometry; Immunohistochemistry (IHC); Other Technologies
  • 3) By Application: Oncology; Infectious diseases; Cardiovascular; Neurology; Genetic disorders; Other Applications
  • 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Pharmaceutical and biotechnology Companies; Other End-Users
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Bayer AG; Novartis AG; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Precision Diagnostics Market Characteristics

3. Precision Diagnostics Market Trends And Strategies

4. Precision Diagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Precision Diagnostics Market Size and Growth

  • 5.1. Global Precision Diagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Precision Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Precision Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Precision Diagnostics Market Segmentation

  • 6.1. Global Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Genetic Tests
  • Esoteric tests
  • Other Types
  • 6.2. Global Precision Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization (ISH)
  • Mass Spectrometry
  • Immunohistochemistry (IHC)
  • Other Technologies
  • 6.3. Global Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Infectious diseases
  • Cardiovascular
  • Neurology
  • Genetic disorders
  • Other Applications
  • 6.4. Global Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical and biotechnology Companies
  • Other End-Users

7. Precision Diagnostics Market Regional And Country Analysis

  • 7.1. Global Precision Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Precision Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Precision Diagnostics Market

  • 8.1. Asia-Pacific Precision Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Precision Diagnostics Market

  • 9.1. China Precision Diagnostics Market Overview
  • 9.2. China Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Precision Diagnostics Market

  • 10.1. India Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Precision Diagnostics Market

  • 11.1. Japan Precision Diagnostics Market Overview
  • 11.2. Japan Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Precision Diagnostics Market

  • 12.1. Australia Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Precision Diagnostics Market

  • 13.1. Indonesia Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Precision Diagnostics Market

  • 14.1. South Korea Precision Diagnostics Market Overview
  • 14.2. South Korea Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Precision Diagnostics Market

  • 15.1. Western Europe Precision Diagnostics Market Overview
  • 15.2. Western Europe Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Precision Diagnostics Market

  • 16.1. UK Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Precision Diagnostics Market

  • 17.1. Germany Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Precision Diagnostics Market

  • 18.1. France Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Precision Diagnostics Market

  • 19.1. Italy Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Precision Diagnostics Market

  • 20.1. Spain Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Precision Diagnostics Market

  • 21.1. Eastern Europe Precision Diagnostics Market Overview
  • 21.2. Eastern Europe Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Precision Diagnostics Market

  • 22.1. Russia Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Precision Diagnostics Market

  • 23.1. North America Precision Diagnostics Market Overview
  • 23.2. North America Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Precision Diagnostics Market

  • 24.1. USA Precision Diagnostics Market Overview
  • 24.2. USA Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Precision Diagnostics Market

  • 25.1. Canada Precision Diagnostics Market Overview
  • 25.2. Canada Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Precision Diagnostics Market

  • 26.1. South America Precision Diagnostics Market Overview
  • 26.2. South America Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Precision Diagnostics Market

  • 27.1. Brazil Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Precision Diagnostics Market

  • 28.1. Middle East Precision Diagnostics Market Overview
  • 28.2. Middle East Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Precision Diagnostics Market

  • 29.1. Africa Precision Diagnostics Market Overview
  • 29.2. Africa Precision Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Precision Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Precision Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Precision Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Precision Diagnostics Market Competitive Landscape
  • 30.2. Precision Diagnostics Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Abbott Laboratories
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Precision Diagnostics Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. Amgen Inc.
  • 31.3. Koninklijke Philips N.V.
  • 31.4. Becton Dickinson and Company (BD)
  • 31.5. Thermo Fisher Scientific Inc.
  • 31.6. Quest Diagnostics Inc.
  • 31.7. Seimens Healthineers AG
  • 31.8. Agilent Technologies Inc.
  • 31.9. PerkinElmer Inc.
  • 31.10. Beckman Coulter Inc.
  • 31.11. Charles River Laboratories International Inc.
  • 31.12. Sysmex America Inc.
  • 31.13. Waters Corporation
  • 31.14. Bio-Rad Laboratories Inc.
  • 31.15. Bruker Corporation

32. Global Precision Diagnostics Market Competitive Benchmarking

33. Global Precision Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Precision Diagnostics Market

35. Precision Diagnostics Market Future Outlook and Potential Analysis

  • 35.1 Precision Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Precision Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Precision Diagnostics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer